Ucb Sa Adr Stock Performance

UCBJY Stock  USD 58.22  1.22  2.14%   
On a scale of 0 to 100, UCB SA holds a performance score of 25. The firm owns a Beta (Systematic Risk) of 0.89, which indicates possible diversification benefits within a given portfolio. UCB SA returns are very sensitive to returns on the market. As the market goes up or down, UCB SA is expected to follow. Although it is vital to follow UCB SA ADR existing price patterns, it is good to be conservative about what you can do with the information regarding equity price patterns. Please operates UCB SA ADR downside variance, and the relationship between the total risk alpha and daily balance of power to make a quick decision on whether UCB SA ADR current price history will revert.

Risk-Adjusted Performance

25 of 100

 
Low
 
High
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in UCB SA ADR are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating forward-looking indicators, UCB SA showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow1.3 B
Total Cashflows From Investing Activities-487 M
  

UCB SA Relative Risk vs. Return Landscape

If you would invest  4,188  in UCB SA ADR on December 19, 2023 and sell it today you would earn a total of  1,634  from holding UCB SA ADR or generate 39.02% return on investment over 90 days. UCB SA ADR is currently producing 0.5553% returns and takes up 1.6903% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than UCB, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon UCB SA is expected to generate 2.84 times more return on investment than the market. However, the company is 2.84 times more volatile than its market benchmark. It trades about 0.33 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.17 per unit of risk.

UCB SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as UCB SA ADR, and traders can use it to determine the average amount a UCB SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.3285

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsUCBJY
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.69
  actual daily
14
86% of assets are more volatile

Expected Return

 0.56
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.33
  actual daily
25
75% of assets perform better
Based on monthly moving average UCB SA is performing at about 25% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UCB SA by adding it to a well-diversified portfolio.

UCB SA Fundamentals Growth

UCB Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of UCB SA, and UCB SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on UCB Pink Sheet performance.

About UCB SA Performance

To evaluate UCB SA ADR Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when UCB SA generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare UCB Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand UCB SA ADR market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents UCB's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.

Things to note about UCB SA ADR performance evaluation

Checking the ongoing alerts about UCB SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for UCB SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating UCB SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate UCB SA's pink sheet performance include:
  • Analyzing UCB SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UCB SA's stock is overvalued or undervalued compared to its peers.
  • Examining UCB SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating UCB SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UCB SA's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of UCB SA's pink sheet. These opinions can provide insight into UCB SA's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating UCB SA's pink sheet performance is not an exact science, and many factors can impact UCB SA's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for UCB Pink Sheet analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Please note, there is a significant difference between UCB SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if UCB SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UCB SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.